Main Line Health System — Wynnewood, Pennsylvania

Main Line Health System is a clinical research site located in Wynnewood, Pennsylvania, United States 19096.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Main Line Health System has participated in 3 clinical trials.

Therapeutic areas: Heart Failure, Oral Squamous Cell Carcinoma, Stage IV Resectable Melanoma.

Sponsors: Duke University, PeriRx, Saint John's Cancer Institute.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Main Line Health System?

Main Line Health System has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Main Line Health System conducted?

Main Line Health System has 3 clinical trials on record. Their work covers Heart Failure, Oral Squamous Cell Carcinoma, Stage IV Resectable Melanoma.

Is Main Line Health System accredited by Crixeo Health?

Main Line Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Main Line Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.